Showing results (751-760 of 873) with videos related to

Sort By:
Pageof 88
Journal for Immunotherapy of Cancer|December 9, 2024
DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantationKyra J Fuchs, Marcus Göransson, Michel G D Kester, et al.
European Heart Journal. Digital Health|March 23, 2026
A machine learning model to detect falls mimicking cardiac arrest-related collapse based on wrist-derived accelerometry: the DETECT-2 studyRoos Edgar, Kambiz Ebrahimkheil, Danny Meeuwsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016
Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2Margot J Pont, Dyantha I van der Lee, Edith D van der Meijden, et al.
Nature Communications|January 3, 2024
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumorsJim Middelburg, Marjolein Sluijter, Gaby Schaap, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2021
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapyMiranda H Meeuwsen, Anne K Wouters, Lorenz Jahn, et al.
Oncotarget|October 27, 2016
Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effectEsther A Kleibeuker, Emmanouil Fokas, Philip D Allen, et al.
Cellular and Molecular Life Sciences : CMLS|September 20, 2023
Human CD34<sup>+</sup>-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8<sup>+</sup> T cell and NK cell responses in vitro and in vivoJesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, et al.
Scientific Reports|March 15, 2026
Immunoproteomic insights into inflammatory diseases of the critically endangered black rhinoceros (Diceros bicornis)Molly L Corder, Tamara Abulez, Timothy Cleland, et al.
Journal for Immunotherapy of Cancer|June 21, 2022
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinomaRosa A van Amerongen, Renate S Hagedoorn, Dennis F G Remst, et al.
Lancet (London, England)|April 16, 2019
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialDavid A Palma, Robert Olson, Stephen Harrow, et al.
Pageof 88